CM Hospitalar

CM Hospitalar EBITDA per Share

The EBITDA per Share of CM Hospitalar (VVEO3.SA) as of Oct 27, 2026 is 1.68 BRL. In the previous year, EBITDA per Share was -2.73 BRL — a change of -161.61% (higher).

EBITDA per Share

1.68BRL

YoY

-161.61%

Last updated:

EBITDA per Share of CM Hospitalar is 2025 1.68 BRL. EBITDA per Share of CM Hospitalar was 2024 -2.73 BRL. It decreases by -161.61% higher compared to the previous year.

The CM Hospitalar EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
0.40 BRL
Jan 1, 2019
0.39 BRL
Jan 1, 2020
0.74 BRL
Jan 1, 2021
1.96 BRL
Jan 1, 2022
1.80 BRL
Jan 1, 2023
1.99 BRL
Jan 1, 2024
-2.73 BRL
Jan 1, 2025
1.68 BRL
The CM Hospitalar EBITDA per Share history
YEAREBITDA per ShareYoY
1.68BRL-161.61%
-2.73BRL-237.41%
1.99BRL+10.56%
1.80BRL-8.30%
1.96BRL+166.42%
0.74BRL+89.38%
0.39BRL-3.15%
0.40BRL+107.80%
0.19BRL—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CM Hospitalar Stock analysis

What does CM Hospitalar do? CM Hospitalar SA provides healthcare services as a middleman between pharmaceutical industries and hospitals, clinics, home care, and health institutions in both private and public markets. The company operates throughout Brazil with a commercial and logistical structure, focusing on the export, import, production, representation, storage, distribution, and shipment of medicines, including special control and wholesale trade. It generates revenue through its role as an intermediary in the health products trade, serving institutions across Brazil's private and public healthcare sectors. The firm's business model relies on its comprehensive distribution network for medicines and hospital supplies, acting as a key link in the supply chain. By handling export, import, production, and wholesale activities, CM Hospitalar SA facilitates transactions between manufacturers and healthcare providers, ensuring efficient delivery of health products to its clients. Its medium and long-term strategy includes acquiring companies in the segment to strengthen its commercial presence nationwide. With 6,000 full-time employees, the company supports its operations across Brazil, managing the entire supply chain from production to distribution. CM Hospitalar SA's revenue streams are derived from its intermediary services in the health products trade, targeting hospitals, clinics, home care services, and health institutions that require consistent access to medicines and hospital supplies through its established logistics and commercial infrastructure. CM Hospitalar is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CM Hospitalar stock

EBITDA per Share of CM Hospitalar is 1.68 BRL in 2025.

EBITDA per Share of CM Hospitalar changed from -2.73 BRL to 1.68 BRL, representing a -161.61% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share CM Hospitalar since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — CM Hospitalar

All Key Metrics — CM Hospitalar